BAM
SSKN

Brave Asset Management’s Strata Skin Sciences SSKN Stock Holding History

Brave Asset Management’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10
Closed -$2K – 437
2014
Q2 		$2K Buy
10
+8
+400% +$1.81K ﹤0.01% 426
2014
Q1 		$1K Hold
2
– – ﹤0.01% 417
2013
Q4 		$1K Buy
+2
New +$716 ﹤0.01% 420

Other funds holding SSKN

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TH
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Brave Asset Management's SSKN Position: Q3 2014 in Review

Brave Asset Management sold out of Strata Skin Sciences (SSKN) in Q3 2014, closing a stake of 10 shares — an estimated $2K sold.

Brave Asset Management first reported a position in SSKN in Q4 2013 and held it in 3 quarters. The position peaked at $2K in Q2 2014. 22 funds tracked by Wall St. Rank hold SSKN as of Q3 2014.

  • Brave Asset Management reported no remaining Strata Skin Sciences position as of Q3 2014 after selling out during the quarter.
  • Brave Asset Management sold 10 Strata Skin Sciences shares in Q3 2014, an estimated $2K.
  • Brave Asset Management first reported a position in Strata Skin Sciences in Q4 2013 and held it in 3 quarters.
  • Brave Asset Management's Strata Skin Sciences position peaked at $2K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q3 2014.

Based on Brave Asset Management's 13F filing for Q3 2014, filed 6 Nov 2014.